Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study Blood Cancer J
Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma Future Oncol
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy Front Immunol
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort Blood Cancer J
Incidence, Risk Factors, and Impact of Early Cardiac Toxicity after Allogeneic Hematopoietic Cell Transplantation Blood Adv
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype BRIT J HAEMATOL
Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity J Clin Invest
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin Cell Rep
HHV8 and EBV-negative primary effusion-based lymphoma: A case report of a new provisional entity and review of literature Clin Case Rep
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia Cancer Cell Int